Cart
0
Get 20% Free Customization In This Report
Buy this report from - $3111

Wound Biologics Market by Product (Growth Factors, Enzyme-based Formulations, and Skin Substitutes), Application (Acute Wounds, Chronic Wounds, Burn Cases, and Surgical Wounds), and End User (Hospitals, Community Health Services, Ambulatory Surgical Centers, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

LI 173970
Pages: NA
Apr 2018 | 375 Views
face gplus_n
Author's : NA
Tables: NA
Charts: NA
twit_n pr_n

Wound biologics are healing therapies that enable re-establishment of the innate repair mechanisms, and may also involve the application of active biological agents, such as plant-derived active biomolecules that exhibit antimicrobial, antioxidant, or anti-inflammatory attributes. Biologic dressings prevent wounds from heat loss, evaporative water loss, protein and electrolyte loss, and contamination. In addition, they allow autolytic debridement and develop a granular wound bed.

The major factors that drive the growth of global wound biologics market are rise in demand for various biologics in advanced wound care field and increase in inclination towards products that enhance therapeutic outcomes. In addition, field of wound biologics is changing rapidly with the introduction of advanced products from key market players, which is expected to propel the growth of the market. However, availability of low reimbursements and possible complications after undergoing wound biologics treatment restrict the market growth. Conversely, untapped emerging economies with unmet medical needs are expected to provide new opportunities for the key players manufacturing wound biologics.

The report segments the global wound biologics market based on application, end user, product, and geography. On the basis of product, the market is categorized into growth factors, enzyme-based formulations, and skin substitutes. In terms of application, it is divided into acute wounds, chronic wounds, burn cases, and surgical wounds. By end user, it is classified into hospitals, community health services, ambulatory surgical centers, and others. Regionally, the market is analyzed in North America, Europe, Asia-Pacific, and LAMEA.

The key players operating in the market include Acelity L.P. Inc., Integra LifeSciences, Smith & Nephew Plc., Organogenesis Inc., MiMedx Group, Osiris Therapeutics, Inc., Derma Sciences, Inc., Soluble Systems, LLC, ConvaTec Group Plc., and Applied Biologics.

Key Benefits

  • This report provides an extensive analysis of the current & emerging market trends and dynamics in the global wound biologics market.
  • Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities across the geographies.
  • This report entails the detailed quantitative analysis of the current market and estimations from 2016 to 2023 to identify the prevailing opportunities.
  • Comprehensive analysis of factors that drive and restrict the market growth is provided in the report.
  • Region- and country-wise market conditions are comprehensively analyzed in the report.

Wound Biologics Market Key Segments:

By Product

  • Growth Factors
  • Enzyme-based Formulations
  • Skin Substitutes

By Application

  • Acute Wounds
  • Chronic Wounds
  • Burn Cases
  • Surgical Wounds

By End User

  • Hospitals
  • Community Health Services
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • South Korea
    • India
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Venezuela
    • Saudi Arabia
    • South Africa
    • Argentina
    • Rest of LAMEA
 

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities

Chapter: 4 GLOBAL WOUND BIOLOGICS MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. GROWTH FACTORS

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. ENZYME-BASED FORMULATIONS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.4. SKIN SUBSTITUTES

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

Chapter: 5 GLOBAL WOUND BIOLOGICS MARKET, BY APPLICATION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. ACUTE WOUNDS

5.2.1. Market size and forecast

5.3. CHRONIC WOUNDS

5.3.1. Market size and forecast

5.4. BURN CASES

5.4.1. Market size and forecast

5.5. SURGICAL WOUNDS

5.5.1. Market size and forecast

Chapter: 6 GLOBAL WOUND BIOLOGICS MARKET, BY END USER

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. HOSPITALS

6.2.1. Market size and forecast

6.3. COMMUNITY HEALTH SERVICES

6.3.1. Market size and forecast

6.4. AMBULATORY SURGICAL CENTERS

6.4.1. Market size and forecast

6.5. OTHERS

6.5.1. Market size and forecast

Chapter: 6 GLOBAL WOUND BIOLOGICS MARKET, BY REGION

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast

6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast

6.2.4. North America Wound Biologics Market by Product
6.2.5. North America Wound Biologics Market by Application 
6.2.6. North America Wound Biologics Market by End User 

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast

6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Italy market size and forecast
6.3.3.5. Spain market size and forecast
6.3.3.6. Rest of Europe market size and forecast

6.3.4. Europe Wound Biologics Market by Product
6.3.5. Europe Wound Biologics Market by Application
6.3.6. Europe Wound Biologics Market by End User

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast

6.4.3.1. Japan market size and forecast
6.4.3.2. China market size and forecast
6.4.3.3. Australia market size and forecast
6.4.3.4. India market size and forecast
6.4.3.5. South Korea market size and forecast
6.4.3.6. Rest of Asia-Pacific market size and forecast

6.4.4. Asia-Pacific Wound Biologics Market by Product
6.4.5. Asia-Pacific Wound Biologics Market by Application
6.4.6. Asia-Pacific Wound Biologics Market by End User

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast

6.5.3.1. Brazil market size and forecast
6.5.3.2. Argentina market size and forecast
6.5.3.3. Venezuela market size and forecast
6.5.3.4. Saudi Arabia market size and forecast
6.5.3.5. South Africa market size and forecast
6.5.3.6. Rest of LAMEA market size and forecast

6.5.4. LAMEA Wound Biologics Market by Product
6.5.5. LAMEA Wound Biologics Market by Application
6.5.6. LAMEA Wound Biologics Market by End User

Chapter: 7 COMPANY PROFILES

7.1. ACELITY L.P. INC.

7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments

7.2. INTEGRA LIFESCIENCES

7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments

7.3. SMITH & NEPHEW PLC

7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments

7.4. ORGANOGENESIS INC.

7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments

7.5. MIMEDX GROUP

7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments

7.6. OSIRIS THERAPEUTICS, INC.

7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments

7.7. DERMA SCIENCES, INC.

7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments

7.8. SOLUBLE SYSTEMS, LLC

7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments

7.9. CONVATEC GROUP PLC.

7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments

7.10. APPLIED BIOLOGICS.

7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments

 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
 

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

 

Get More Information About This Report

For any queries about purchasing this report, Please fill the form below:

Please input the above text in the input box or click refresh

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts